Sunshine Biopharma (SBFM) Operating Leases (2019 - 2025)
Historic Operating Leases for Sunshine Biopharma (SBFM) over the last 5 years, with Q3 2025 value amounting to $636708.0.
- Sunshine Biopharma's Operating Leases rose 4460.84% to $636708.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $636708.0, marking a year-over-year increase of 4460.84%. This contributed to the annual value of $744724.0 for FY2024, which is 3815.87% up from last year.
- Per Sunshine Biopharma's latest filing, its Operating Leases stood at $636708.0 for Q3 2025, which was up 4460.84% from $706530.0 recorded in Q2 2025.
- Sunshine Biopharma's 5-year Operating Leases high stood at $744724.0 for Q4 2024, and its period low was $440298.0 during Q3 2024.
- Moreover, its 4-year median value for Operating Leases was $604993.0 (2023), whereas its average is $596439.4.
- In the last 5 years, Sunshine Biopharma's Operating Leases crashed by 2244.18% in 2024 and then skyrocketed by 5262.93% in 2025.
- Sunshine Biopharma's Operating Leases (Quarter) stood at $642232.0 in 2022, then dropped by 16.07% to $539035.0 in 2023, then skyrocketed by 38.16% to $744724.0 in 2024, then decreased by 14.5% to $636708.0 in 2025.
- Its Operating Leases was $636708.0 in Q3 2025, compared to $706530.0 in Q2 2025 and $722199.0 in Q1 2025.